#Saudi Arabia #Co-Diagnostics #CoMira Diagnostics #Sudair

CoMira Diagnostics Engages with Saudi Industry for Local Manufacturing

Introduction
CoMira Diagnostics, the joint venture of Co-Diagnostics, Inc., is gearing up for an important engagement at the NUWATIN 2026 Forum. This forum is part of Saudi Arabia's Vision 2030 initiative designed to boost local manufacturing and technology transfer. This invitation from the Saudi Ministry of Industry and Mineral Resources underscores the strategic role CoMira aims to play in the Kingdom's healthcare landscape.

The NUWATIN 2026 Forum

Scheduled for November 2026, the forum is expected to attract government officials and industry stakeholders focused on industrial investments, technology exchange, and cooperation opportunities. CoMira's participation marks a significant step in fostering collaboration between international manufacturers and Saudi entities. This forum will be graced by His Royal Highness Prince Abdulaziz bin Salman Al Saud, highlighting its importance in the Kingdom's industrial strategy.

Strategic Objectives

CoMira Diagnostics will focus on enhancing relationships with governmental and industrial partners while advancing its plans to establish a molecular diagnostics manufacturing facility. In its discussions, the company aims to explore technology transfer processes, local manufacturing capabilities, and safeguard governmental support for its operations in the region.

Dwight Egan, the CEO of Co-Diagnostics, expressed optimism about this engagement, saying, “Saudi Arabia represents a vital opportunity for us as we work to broaden the reach of our diagnostics technologies. Our plans for a local manufacturing presence align seamlessly with the Kingdom's goals.”

Local Manufacturing Facility

The recent execution of a lease agreement for CoMira's upcoming facility in Sudair Industrial City further reinforces its commitment to the Saudi market. This facility will play a crucial role in localizing Co-Diagnostics' proprietary PCR technologies and contributing to the Kingdom's burgeoning healthcare manufacturing sector.

Ihssan Rjoob, CEO of CoMira, articulated the vision for the local facility, stating, “Through our initiative, we aim to localize advanced molecular diagnostics, nurture Saudi talent, and fortify the healthcare supply chain within the Kingdom.”

Aligning with Saudi Vision 2030

The establishment of CoMira's manufacturing capabilities is closely linked to the objectives of Saudi Vision 2030, which is focused on diversifying the economy and enhancing local industrial capabilities. The initiative to increase local manufacturing is expected to provide CoMira with a competitive edge, particularly as government procurement increasingly favors locally produced healthcare solutions.

Conclusion

CoMira’s invitation to the NUWATIN 2026 Forum is a reflection of the growing emphasis on industrial collaboration within the Kingdom. As CoMira prepares to make strides in Saudi Arabia’s healthcare landscape, it represents a significant opportunity to support local manufacturing and technology transfer. Undoubtedly, this collaboration will not only benefit CoMira but also contribute to the overarching goals of advancing the Kingdom’s industrial capabilities and healthcare system.

Disclaimer: The technologies under the Co-Dx brand, including the PCR Home® and PCR Pro®, are subject to regulatory review and are not currently available for sale.